[Effectiveness of ursodeoxycholic acid in cholesterosis of the gallbladder]

Terapevticheskii arkhiv · 2003 · vol. 75(2) , pp. 35–8 · PMID:12685388
Non-randomised trial OA: closed
View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-08-31 ⓘ

Ursodeoxycholic acid effectively treats gallbladder cholesterosis by dissolving cholesterol polyps and improving contraction function, particularly with prolonged therapy exceeding ten months.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

AIM: To study efficacy of ursodesoxycholic acid (UA) drugs in the treatment of polypous and polyporeticular cholesterosis of the gallbladder (CGB), including combination with biliary sludge, with reference to terms of the treatment. MATERIAL AND METHODS: A contraction function of the gallbladder was studied ultrasonically in 74 CGB patients treated with UA drugs. The treatment lasted from 1 month to 1.5 years. A response (complete or partial dilution of cholesterol polyps) was recorded in 71.6% patients. Therapy was less effective if the gallbladder contained biliary sludge, heterogeneous bile and suspension, dense bile. The lytic therapy effect improved with treatment duration. Complete dissolving of cholesterol polyps was achieved after at least 10-month treatment. The treatment also brought about a marked choleretic effect and an increased ejection fraction of the gallbladder. CONCLUSION: UA drugs can be used in the treatment of CGB.

My notes (saved in your browser only)

MeSH descriptors

Gallbladder Diseases Ursodeoxycholic Acid Adolescent Adult Aged Female Gallbladder Diseases Gallbladder Diseases Gallbladder Diseases Humans Male Middle Aged Treatment Outcome Ultrasonography Ursodeoxycholic Acid

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-25T09:32:14.900964+00:00
pubmed
last seen: 2026-10-08T21:00:58.458861+00:00